- Tytuł:
- Analysis of Japanese patients from the AUGMENT phase III study of lenalidomide + rituximab (R) vs. rituximab + placebo in relapsed/refractory indolent non-Hodgkin lymphoma.
- Autorzy:
- Temat:
-
THERAPEUTIC use of antineoplastic agents
RESEARCH
RESEARCH methodology
CANCER relapse
EVALUATION research
MEDICAL cooperation
TREATMENT effectiveness
PLACEBOS
RANDOMIZED controlled trials
COMPARATIVE studies
BLIND experiment
LYMPHOMAS - Źródło:
- International Journal of Hematology; Mar2020, Vol. 111 Issue 3, p409-416, 8p
Czasopismo naukowe